Selective Targeting of Cancer Cells by Copper Ionophores: An Overview.

Selective Targeting of Cancer Cells by Copper Ionophores: An Overview.
复制标题

铜离子载体选择性靶向癌细胞:概述。

DOI:
10.3389/fmolb.2022.841814
复制
发表时间:
2022
影响因子:
5
通讯作者:
Oliveri V
Oliveri V
中科院分区:
生物学3区
文献类型:
--
作者:
Oliveri V

文献摘要

参考文献

被引文献

相似文献

传统的癌症疗法遭受严重的脱靶效应,因为它们中的大多数靶向细胞的关键方面,这些方面通常由所有快速增殖的细胞共享。新治疗剂的开发应旨在增加选择性,从而减少副作用。此外,这些药物应克服癌细胞耐药性并靶向癌症干细胞。与正常细胞相比,一些铜离子载体在优先诱导癌细胞铜沉积方面具有内在选择性,因此在这一方向上显示出了希望。在这里,讨论了铜离子载体,重点是对癌细胞的选择性和负责这种选择性的机制。提出的策略,以进一步提高铜离子载体的癌细胞的靶向,也报告。
Conventional cancer therapies suffer from severe off-target effects because most of them target critical facets of cells that are generally shared by all rapidly proliferating cells. The development of new therapeutic agents should aim to increase selectivity and therefore reduce side effects. In addition, these agents should overcome cancer cell resistance and target cancer stem cells. Some copper ionophores have shown promise in this direction thanks to an intrinsic selectivity in preferentially inducing cuproptosis of cancer cells compared to normal cells. Here, Cu ionophores are discussed with a focus on selectivity towards cancer cells and on the mechanisms responsible for this selectivity. The proposed strategies, to further improve the targeting of cancer cells by copper ionophores, are also reported.
DOI: 10.1016/j.freeradbiomed.2019.12.001
发表时间: 2020-05-20
影响因子: 7.4
作者:
Bao, Xia-Zhen;Wang, Qi;Zhou, Bo
通讯作者: Zhou, Bo
DOI: 10.1016/j.bmcl.2020.127148
发表时间: 2020-06-01
影响因子: 2.7
作者:
Bakthavatsalam S;Wiangnak P;George DJ;Zhang T;Franz KJ
通讯作者: Franz KJ
DOI: 10.1007/s11356-014-3970-9
发表时间: 2015-05-01
影响因子: 5.8
作者:
Ding, Xiao;Jiang, Meng;Wang, Luhua
通讯作者: Wang, Luhua
DOI: 10.1073/pnas.1116227108
发表时间: 2012-01-03
影响因子: 11.1
作者:
Donnelly, Paul S.;Liddell, Jeffrey R.;Crouch, Peter J.
通讯作者: Crouch, Peter J.
DOI: 10.3390/pharmaceutics12050466
发表时间: 2020-05-01
期刊: PHARMACEUTICS
影响因子: 5.4
作者:
Gaal, Aniko;Garay, Tamas M.;Szoboszlai, Norbert
通讯作者: Szoboszlai, Norbert